WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Hakeem Jeffries isn't speaker, but might be the most powerful person in CongressClaire Foy puts on a lovedUK local elections: Labour flips seats it hasn't held in decadesCarlos Alcaraz withdraws from Italian Open with right forearm injuryImprovised explosive kills three and wounds seven in Pakistan’s southwest Baluchistan provinceBaby Reindeer creator Richard Gadd reveals why he has banned his parents from watching Netflix hitJill Biden recognizes fellow teachers at White House dinnerKlopp says he has 'no problem' with Salah after touchline spatThe UK government acted unlawfully in approving a climate plan, a High Court judge has ruledChina highway collapse: Vice Premier in Guangdong to oversee rescue efforts